MULTIFUNCTIONAL LINEAR PEN

K100501 · AtriCure, Inc. · OCL · Jun 18, 2010 · General, Plastic Surgery

Device Facts

Record IDK100501
Device NameMULTIFUNCTIONAL LINEAR PEN
ApplicantAtriCure, Inc.
Product CodeOCL · General, Plastic Surgery
Decision DateJun 18, 2010
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4400
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Multifunctional linear pen is a sterile, single use electrosurgery device intended to ablate cardiac tissue during cardiac surgery using radiofrequency (RF) energy when connected directly to the AtriCure Ablation and Sensing Unit or to the ASU Source Switch in Ablation mode and the Multifunctional linear pen may be used for temporary cardiac pacing, sensing, recording, and stimulation during the evaluation of cardiac arrhythmias during surgery when connected to a temporary external cardiac pacemaker or recording device.

Device Story

Hand-held, sterile, single-use electrosurgical instrument; used during cardiac surgery. Input: RF energy from AtriCure Ablation and Sensing Unit (ASU) or ASU Source Switch; or electrical signals from external pacemaker/recorder. Operation: Operator-controlled via footswitch to deliver RF energy for tissue ablation; or passive connection for pacing/sensing/recording. Output: Ablated cardiac tissue; or diagnostic cardiac signals/stimulation. Used in OR by surgeons/clinicians. Benefits: Enables surgical ablation of cardiac tissue and intraoperative arrhythmia evaluation.

Clinical Evidence

No clinical data. Bench testing and in-vivo testing conducted to evaluate conformance to product specifications and substantial equivalence to predicate devices. Testing confirmed the device's ability to pace, sense, stimulate, and ablate cardiac tissue.

Technological Characteristics

Hand-held electrosurgical instrument; RF energy source; sterile, single-use. Biocompatibility tested per ISO 10993-1. Connectivity: Direct connection to AtriCure ASU or external pacemaker/recorder.

Indications for Use

Indicated for patients undergoing cardiac surgery requiring cardiac tissue ablation or evaluation of cardiac arrhythmias via temporary pacing, sensing, recording, or stimulation.

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K10 0561 1/2 ## ATRICURE MULTIFUNCTIONAL LINEAR PEN 510(k) SUMMARY ## General Information # JUN 1 8 2010 | Date Compiled | February 16, 2010 | |----------------|------------------------------------------------------------------------------------| | Classification | Class II (Surgical device, for ablation of cardiac tissue) | | Product Code | OCL | | Trade Name | AtriCure Multifunctional linear pen | | Manufacturer | AtriCure, Inc<br>6217 Centre Park Drive<br>West Chester, OH 45069 | | Contact | James L. Lucky<br>VP of Quality Assurance and Regulatory Affairs<br>(513) 755-5754 | ### Indications for Use The Multifunctional linear pen is a sterile, single use electrosurgery device intended to ablate cardiac tissue during cardiac surgery using radiofrequency (RF) energy when connected directly to the AtriCure Ablation and Sensing Unit or to the ASU Source Switch in Ablation mode and the Multifunctional linear pen may be used for temporary cardiac pacing, sensing, recording, and stimulation during the evaluation of cardiac arrhythmias during surgery when connected to a temporary external cardiac pacemaker or recording device. #### Predicate Devices The predicate devices for the AtriCure Multifunctional linear pen are the AtriCure Isolator Transpolar pen (K050459, K061593) and the AtriCure Coolrail linear pen (K073605). #### Device Description The Multifunctional linear pen is a hand-held, sterile, single patient use electrosurgical instrument intended to ablate cardiac tissue during cardiac surgery using radiofrequency energy. When the pen is connected to the AtriCure Ablation and Sensing Unit (ASU) directly or via the AtriCure ASU Source Switch in ablation mode, the device delivers RF energy for cardiac tissue ablation when the operator presses the Footswitch. When the pen is connected to a commercially available temporary pacemaker or recorder the pen is used for temporary cardiac pacing, sensing, recording, or stimulation for the evaluation of cardiac arrhythmias during surgery. #### Materials {1}------------------------------------------------ All materials used in the manufacture of the AtriCure Multifunctional linear pen are suitable for their intended use and have been used in numerous previously cleared products. Testing was conducted in Accordance with ISO 10993-1 to ensure appropriate biocompatibility of all materials. #### Testing Appropriate product testing was conducted to evaluate conformance to product specification and substantial equivalence to predicate devices. In-vitro and in-vivo testing demonstrated that the Multifunction linear pen is able to pace, sense, and stimulate and ablate cardiac tissue as safely and effectively as the AtriCure Isolator Transpolar pen and the AtriCure Coolrail linear pen. ### Summary of Substantial Equivalence The Multifunctional linear pen is equivalent to the predicate products. The indications for use, basic overall function, and materials used are substantially equivalent. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features a stylized eagle with its wings spread, facing right. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle. The seal is black and white. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002 # JUN 1 8 2010 AtriCure, Inc. c/o Mr. James Lucky, RAC Vice President of Quality Assurance and Regulatory Affairs 6217 Centre Park Dr. West Chester, OH 45069 Re: K100501 Trade/Device Name: AtriCure Multifunctional Linear Pen Regulation Number: 21 CFR §878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II (two) Product Code: OCL Dated: May 20, 2010 Received: May 21, 2010 · Dear Mr. Lucky: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must {3}------------------------------------------------ Page 2 - Mr. James Lucky comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industrv/default.htm. Sincerely yours, For Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Indications for Use K100501 510(k) Number (if known) _ Device Name: AtriCure Multifunctional linear pen Indications for Use: - The Multifunctional Linear Pen is a sterile, single use electrosurgery device intended to ablate cardiac . tissue during cardiac surgery using radiofrequency (RF) energy when connected directly to the AtriCure Ablation and Sensing unit (ASU) or to the ASU Source Switch in Ablation mode. - The Multifunctional Linear Pen may be used for temporary cardiac pacing, sensing, recording, and . stimulation during the evaluation of cardiac arrhythmias during surgery when connected to a temporary external cardiac pacemaker or recording device. Prescription Use X (Part 21 CRF 801 Subpart D) AND/OR Over-The-Counter Use (21 CRF 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) WMP (Division Sign-Off) Division of Cardiovascular Devices 510(k) Numb
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%